Impact of COVID-19 on the Medtech Supply Chain

What COVID-19 has shown us is that too many companies are not fully prepared for the supply chain disruptions they are experiencing. In fact, only ~10 percent of the companies Jabil recently surveyed across seven industries thought their predictive supply chain management approach had performed well during the current pandemic. Joe McBeth, Vice President, Global Supply Chain, discusses the impact of COVID-19 on the Medtech supply chain with Medical Product Outsourcing (MPO). Read the full article here.